Phototherapy
Study Data from University Hospital Provide New Insights into Phototherapy
Published in Drug Week, October 28th, 2011
2011 OCT 28 -- "Interstitial photodynamic therapy (iPDT) is being investigated for the treatment of high-grade human brain malignancies. In recent clinical studies, fluorescence monitoring during iPDT of glioblastoma multiforme has revealed patient-specific accumulation of photosensitizer (aminolevulinic acid (ALA) induced protoporphyrin IX, PplX) and its photobleaching kinetics," scientists writing in the journal Photodiagnosis and Photodynamic Therapy report.
"As photosensitizer degradation, also referred to as photobleaching, and tissue damage are caused by the same underlying processes, the photobleaching kinetics might provide a tool for...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
Source: Drug Week (2011-10-28)
More Articles from Drug Week
- Urinary Tract
Common medications can contribute to lower urinary tract symptoms in men - Separation Science
Data on Separation Science Reported by Researchers at University of Nebraska - Waste Management Research
Data on Waste Management Research Reported by Researchers at University of Technology - Heparin Therapy
Findings from A.J. Gozzo et al in Heparin Therapy Reported - Cancer Therapy
Findings from Cancer Center Broaden Understanding of Cancer Therapy - Genistein Therapy
Fourth Military Medical University Details Research in Genistein Therapy - More from this issue of Drug Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
